The current method to determine the need for chelation in Pbtoxic children (blood Pb: 25-55 ug/dl; EP >35 ug/dl) is based on the result of the CaNa2EDTA provocative test (PbP). The PbP requires an injection and an 8-hour urine collection -difficult to achieve in young children. In this study, a low energy x-ray generator with a silver anode was used to measure Pb L, XRF from the tibias of 18 children. With the leg immobilized, partially polarized photons were directed at the anteromedial skin surface of the mid-tibia. Based on spectra from a leg phantom and from an amputated adult leg, the nominal detection limit was22 ug Pb/gm of bone, when the skin surface dose reached 1.0 rad. Bone Pb XRF measurements were performed 1 week before the PbP and compared to outcomes on the PbP. The results were:
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PbP Positive PbP Negative XRF: 2 2 ug Pb/gm of bone 6 0 XRF: : 2 ug Pb/gm of bone 5 5 A nominal XRF measurement of > 2 ug Pb/gm of bone was unerringly predictive of a positive PbP in this group. Undetectable bone Pb by XRF did not discriminate between Pb-toxic children with positive and negative PbP's. In L non-Pb-toxic XRF-positive children, the blood Pb levels were 17 and 20 ugldl. Non-invasive XRF measurements of cortical bone Pb could be a rapid method to determine the need for chelation in large populations of children.
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We evaluated E-cenicillamine ( a ) to determine --its efficacy in low-level plumbisn (25-40 mgldl) .
Two groups were ccsnpared: Cases (n=84) were treated with PCN; controls (n=37) received no chelation therapy. Patients were followed at regular intervals for a mean of 200 days; none had received chelation therapy for 3 m n t h s prior to s t d y entry. Mean FUi dose was 27.5 mg/kq/d. Although the vaccine against Haemophilus influenza? type b (Hib) is recommended for all children 24-60 months of age and high risk children 18-23 months of age, there is little information about the extent to which these recommendations have been implimented. To assess the use of the vaccine we randomly selected from the hospital logs 202 (2.5%) of the 8,026 children who were born at Yale-New Haven Hospital and were between 18 and 36 months of age on 2/28/86. Parents of the childrm were interviewed and their physicians were contacted to ascertain whether the child had received the vaccine. After children were excluded because of: inability to locate them (12%), refusal to participate (4%). having moved out of state (2%). death (2%), prior Hib disease (1%) and refusal of the physician to participate (I%), 157 children (78%) were enrolled in the study. Overall, 75 children (48%) had received the vaccine. The vaccine had been received by 2 of 28 children (7%) between 18 and 23 months of age and by 73 of 129 children (57%) between 24 and 36 months of age.
Among children whose day care status was known, 17/33 (52%) win attended group day care and 35/77 (45%) who did not attend group day care had received the vaccine. Among children between 24 and 36 months of age, 55/87 (63%) who attended private physicians, 14/28 (50%) who attended prepaid health maintenance organizations, but only 4/14 (29%) who attended public clinics (~<0.05) had received the vaccine. Although widespread implimentation of recommendations for universal immunization had begun 10 months after licensure of the Hib vaccine, rates of immunization were lower among indigent patients who are at increased risk of disease. National manpower needs, length and clinicall research mix of fellowships, and incentives to attract residents to PR training, and trainees to faculty positions are important issues. We surveyed 142 American and Canadian pediatric chairpersons for their attitudes, and departmental clinical, research and economic needs related to rheumatology. A 28 item questionnaire utilized an educational psychologist, and a biostatistician, to ensure optimal content clarity, completion speed, and statistical design. The response rate was 77% (1101142). 71 departments had a PR, with 75% full-and 25% part-time. The chairs recruiting priority for a new full-time PR was "moderate-high" in 38X. Department size was: 15-25 MD and PhD faculty-24%; 26-40 faculty-26%; 41-75 faculty-34%; (76-164; 39 Departments had 0-10% grant support of faculty salaries; 34 had 12-25%; 23 had 26-5@%, and 5 had 51-80%. "Acute" disease trained chairpersons were less than half as likely to support having a PR, when compared to a chronic disease chair 65% of chairs believed an allergist/immunologist could provide rheumatic disease care only 0-25% of the time; 69% felt a rheumatologist gave a needed chronic disease/rehabilitation focus. Of interest, 54% of chairs stated that fellowships should be 3 years; another 17% preferred 4 years; all 71% desired a 50% research commitment: 31% of chairs would full/partial fund a rheumatology fellow to fill a faculty need, and 57% would provide 30-100% of initial faculty salaries (2-3 years). This survey reflects concerns about pediatric subspecialty manpower, training and research issues.
PLASMA GLUCOSE VALUES AFTER FIRST FEEDING IN NEONATES. G. Srinivasan, R. Krishnaswamy, R.S. Pildes, and M.K.
-.
Div. of Neonatology, Cook County Hosp., TK Chicago Med. Schl., and the Univ. of Illinois. Cheo.IL . " . To identify the type of feeding that will raise plasma glucose (G) most effectively in the first hours after birth, plasma G was measured before and after first feeding at 4hrs of age. 43 term neonates(NB) were randomized into three groups: 20cc of 5% D/W, 10% D/W or formula (20 cal/oz). MeantS.D. birth weight was 3158t306gms. length 49.4t1.4cm, head circumference 33.7t1.2cm, gest. age 39.7'1.5wks.
Apgar scores ranged from 7 to 9. Six NB were born by C-section and the remaining 37 by vaginal delivery. All infants were healthy and appropriate for gest. age. Plasma glucose was measured prior to and 1, 2, and 4 hrs after feedinp and are listed in There was a significant correlation between time of passage of meconium and birth wt. (r = -0.489, p<0.001) and gest. age (r = -0.334, p C0.01); no significant correlation was noted with Apgar score, feeding, peak bilirubin levels, phototherapy or electrolytes. Time of passage was significantly longer in P with HMD vs Transient Tachypnea of Newborn (TTNB) (33'30 vs l6t17hrs,p<0.05).
Only one P had abdominal distension and passed M plug at 47hrs of age; others had no signs of bowel obstruction. In summary, only 213 of P pass M by 24hrs OF age and the remaining 113, even though delayed, do not require diagnostic workup unless associated with other signs of bowel obstruction.
